Phase 2 study of sodium phenylbutyrate in ALS-Reference-Cited by-同舟云学术

Phase 2 study of sodium phenylbutyrate in ALS

Published:2009-01 Issue:2 Volume:10 Page:99-106
ISSN:1748-2968
Container-title:Amyotrophic Lateral Sclerosis
language:en
Short-container-title:Amyotrophic Lateral Sclerosis

Author:

Cudkowicz Merit E.,Andres Patricia L.,Macdonald Sally A.,Bedlack Richard S.,Choudry Rabia,Brown Jr Robert H.,Zhang Hui,Schoenfeld David A.,Shefner Jeremy,Matson Samantha,Matson Wayne R.,Ferrante Robert J.,THE NORTHEAST ALS AND THE NATIONAL

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neurology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/17482960802320487

Reference27 articles.

1. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

2. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2

3. Treatment of spinal muscular atrophy by sodium butyrate

4. Alteration of the Bcl-x/Bax Ratio in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis: Evidence for the Implication of the p53 Signaling Pathway

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone post-translational modification and heterochromatin alterations in neurodegeneration: revealing novel disease pathways and potential therapeutics;Frontiers in Molecular Neuroscience;2024-09-13

2. Targeting the epigenome with advanced delivery strategies for epigenetic modulators;Bioengineering & Translational Medicine;2024-08-17

3. Sodium Phenylbutyrate and Tauroursodeoxycholic Acid: A Story of Hope Turned to Disappointment in Amyotrophic Lateral Sclerosis Treatment;Clinical Drug Investigation;2024-06-23

4. Unraveling the Connection: Pain and Endoplasmic Reticulum Stress;International Journal of Molecular Sciences;2024-05-03

5. Personalized epigenetics of neurodegenerative diseases;Personalized Epigenetics;2024